Randomized Controlled Trial Comparing Acellular Collagen Biomesh (Pelvisoft) to Polypropylene Mesh(Pelvitex) for Sacral Colpopexy
Primary Purpose
Uterine Prolapse
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
sacral colpopexy
Sponsored by
About this trial
This is an interventional treatment trial for Uterine Prolapse focused on measuring Compare the relative differences between the organic and sythentic materials for sacryl colpopexy.
Eligibility Criteria
Inclusion Criteria:
- Greater than 18 years of age
Exclusion Criteria:
- Prior sacral colpopexy or rectopexy
Contraindication to surgery based on co-existent medical condition
Desire for expectant management or pessary use
Pregnancy or the desire for pregnancy within 24 months of the sacral colpopexy procedure
Sites / Locations
- Urogynecology, 95 Madison Ave.
Outcomes
Primary Outcome Measures
anatomic outcomes,graft-related complications between the two materials, changes in pelvic organ prolapse-related quality of life,subjective changes in sexual function,changes in bowel function and the prolapse related pain present after sacral colpopexy
Secondary Outcome Measures
Full Information
NCT ID
NCT00564083
First Posted
November 26, 2007
Last Updated
March 21, 2011
Sponsor
Atlantic Health System
1. Study Identification
Unique Protocol Identification Number
NCT00564083
Brief Title
Randomized Controlled Trial Comparing Acellular Collagen Biomesh (Pelvisoft) to Polypropylene Mesh(Pelvitex) for Sacral Colpopexy
Study Type
Interventional
2. Study Status
Record Verification Date
November 2007
Overall Recruitment Status
Completed
Study Start Date
December 2005 (undefined)
Primary Completion Date
March 2010 (Actual)
Study Completion Date
June 2010 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Atlantic Health System
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This research protocol is a randomized controlled trial. It is being done to compare and find out the relative differences between the materials, (Pelivisoft) "natural organic mesh" to poly propylene mesh (Pelvitex) "manmade mesh" after a surgery known as sacral colpopexy. This surgery involves supporting the prolapsed vaginal wall with a piece of material (known as a graft) attached to a ligament along your backbone (or sacrum). These materials are both FDA approved and widely used. The following objectives: anatomic outcomes, graft-related complications between the two materials, changes in pelvic organ prolapse-related quality of life, subjective changes in sexual function,changes in bowel function and the prolapse related pain present after sacral colpopexy will be evaluated.
The study visits are all under standard of care. Study questionnaires are unique to the study and will be completed at the enrollment in hospital, 2, 6,12 weeks, 6 months and one year visits The questionnaires are related to bowel function, bladder function, prolapse and sexual activity.
Permission will be requested to contact the patient again 5 years after surgery. Contact in the future will in no way obligate the patient to participate.
There may or may not be direct medical benefits to the participant. Decreased risk of erosion may be a possible benefit if placed in the organic "natural" arm of the study. The information learned from this study may benefit other patients in the future
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Uterine Prolapse
Keywords
Compare the relative differences between the organic and sythentic materials for sacryl colpopexy.
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
120 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
sacral colpopexy
Intervention Description
This surgery involves supporting the prolapsed vaginal wall with a piece of material (known as a graft) attached to a ligament along your backbone (or sacrum)
Primary Outcome Measure Information:
Title
anatomic outcomes,graft-related complications between the two materials, changes in pelvic organ prolapse-related quality of life,subjective changes in sexual function,changes in bowel function and the prolapse related pain present after sacral colpopexy
Time Frame
One year
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Greater than 18 years of age
Exclusion Criteria:
Prior sacral colpopexy or rectopexy
Contraindication to surgery based on co-existent medical condition
Desire for expectant management or pessary use
Pregnancy or the desire for pregnancy within 24 months of the sacral colpopexy procedure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patrick Culligan, MD
Organizational Affiliation
Atlantic Health Urogynecology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Urogynecology, 95 Madison Ave.
City
Morristown
State/Province
New Jersey
ZIP/Postal Code
07960
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
23262939
Citation
Culligan PJ, Salamon C, Priestley JL, Shariati A. Porcine dermis compared with polypropylene mesh for laparoscopic sacrocolpopexy: a randomized controlled trial. Obstet Gynecol. 2013 Jan;121(1):143-51. doi: 10.1097/aog.0b013e31827558dc.
Results Reference
derived
Learn more about this trial
Randomized Controlled Trial Comparing Acellular Collagen Biomesh (Pelvisoft) to Polypropylene Mesh(Pelvitex) for Sacral Colpopexy
We'll reach out to this number within 24 hrs